Debbie remains upbeat as she undergoes radiotherapy

Everyone following Debbie Brewer‘s story on this site knows that last December it was determined she was in remission from mesothelioma – a miracle! – following successful chemoembolization treatment in Germany. Then, in September, she received a worrying report that appeared to show growth in a lymph node in her chest, which showed up on a CT scan. Subsequent tests revealed that there was growth, which would require treatment.

This week, Debbie started radiotherapy on the lymph node. She tells me that the radiotherapy treatment is a 3-week course, Monday to Friday, and depending on how the lymph node responds could go to 5 or 6 weeks.

Doctors also did a biopsy on her right groin area, which was the site where Dr. Vogl introduced the chemoembolization procedure. There is some question about whether the mesothelioma could have seeded at the induction site. Debbie says Dr. Vogl – who is pioneering the chemoembolization treatment at the University in Frankfurt – is hopeful and optimistic that this is not the case. However, the treatment is still experimental, so it is hard to know what to expect, she says. The chemoembolization treatment was done six times, each time in the same area.

The biopsy was done on Tuesday, with doctors taking two samples. Debbie is now waiting on the results.

She is in good spirits and keeping a positive outlook, so I’m sure she’d appreciate the continued well wishes and encouragment. She promises to let us know when she receives the results. You can also read more about Debbie’s story, and the other goings-on in her life, at her own blog, Mesothelioma & Me.

No related posts.

Tags: chemoembolization, Debbie Brewer, Dr. Vogl, mesothelioma

This entry was postedon Wednesday, November 11th, 2009 at 9:38 amand is filed under Events, People, Research/Treatment.You can follow any responses to this entry through the RSS 2.0 feed.You can leave a response, or trackback from your own site.

DiggFacebookMySpaceDel.icio.usStumbleUpon --

Australian doctor researching radiotherapy for treatment of pleural mesothelioma

One of the many mesothelioma community members on Facebook posted a question today about a clinical trial being conducted at the Mesothelioma Center, located at New York-Presbyterian Hospital. MyMeso discussed this clinical trial in a July post. The clinical trial is a program of targeted radiation and chemotherapy protocol for pleural mesothelioma, which is a cancer of the lung’s lining almost always caused by asbestos. In response to the Facebook thread, meso survivor and awareness advocate (read: warrior) Debbie Brewer, who many of you know from her story and updates here (thanks Debbie!), mentioned a similar study currently ongoing in Australia.

Debbie provided a link to a story published in November 2009 by ABC News that outlines the work of specialists at Austin Health Centre in Victoria. The treatment, spearheaded by Dr. Malcolm Feigen, a radiation oncologist at the Centre, uses high doses of radiotherapy, concentrated on specific areas of the lining of the lungs to target mesothelioma tumors.

According to the ABC report, 13 patients participated in a pilot program to test this new targeted radiotherapy treatment. Most had some surgery prior to the radiotherapy treatment, and some also had chemotherapy before or after the treatment, although Dr. Feigen believes the patients showed the most benefit primarily as a result of the radiotherapy regimen.

Participants in the U.S. clinical trial at the Mesothelioma Center receive a multi-modality therapy that incorporates surgery, chemotherapy and radiation therapy in combination.

Listen to the interview with Dr. Feigen about the Australian research, which was broadcast on ABC’s AM morning current affairs program.

No related posts.

Tags: asbestos, Austin, Austin Health Centre, Australia, chemotherapy, Debbie Brewer, Dr. Malcom Feigen, Facebook, mesothelioma, Mesothelioma Center, New York, pleural mesothelioma, radiation, radiotherapy

This entry was postedon Tuesday, February 9th, 2010 at 1:44 pmand is filed under News, Research/Treatment.You can follow any responses to this entry through the RSS 2.0 feed.You can leave a response, or trackback from your own site.

DiggFacebookMySpaceDel.icio.usStumbleUpon --